Looking for volunteers
The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.
NCT06536517 · Johns Hopkins University · Updated 12 Jan 2026
- What is being tested
- Methadone
- For
- Fibroid Uterus
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years and older. About 100 people. The full rules are on the registry page.
- Where
- United States (2 sites)
- When
- Starts or started 7 March 2025, ends Dec 2026. Registered 5 Aug 2024.
- Results
- None posted yet.
In the researchers' words
Currently, there is a nationwide epidemic of opioid abuse and overdose deaths. One source of excess opioids is overprescribing in the postoperative period. This study aims to find the optimal pain medication plan during and after laparoscopic hysterectomy to eliminate long-term opioid use. Given the increasing opioid abuse and over-prescription post-operatively, an effort should be made to determine whether one time dosing of Methadone, a longer opioid analgesics, intra-operatively is an adequate potential in treating postoperative pain after hysterectomy surgeries. The investigators hypothesize that this could minimize the need for additional post-operative and outpatient opioid prescriptions and decrease the adverse effects that are associated with the consumption, including new opioid abuse. Intervention group will receive methadone intraoperatively while the other group would receive short-acting opioids (standard).
Sites
- The Johns Hopkins Bayview Medical CenterBaltimore, Maryland, United States
- The Johns Hopkins HospitalBaltimore, Maryland, United States
